(Q43722712)

26 November 2017

title

Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor (English)

1 reference

26 November 2017

0 references

1 reference

Tan EC

1

1 reference

26 November 2017

Chong SA

2

1 reference

26 November 2017

Mahendran R

3

1 reference

26 November 2017

Dong F

4

1 reference

26 November 2017

Tan CH

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

26 November 2017

published in

Biological Psychiatry

1 reference

26 November 2017

volume

50

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

144-147

1 reference

Pharmacogenetic prediction of clozapine response

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Incidence and risk factors for severe tardive dyskinesia in older patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Tardive dyskinesia associated with fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Familial metoclopramide-induced dystonic reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

102T/C polymorphism of serotonin receptor type 2A gene is not associated with schizophrenia in either Chinese or British populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Guidelines for depot antipsychotic treatment in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Movement Disorders Associated With the Serotonin Selective Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Genetic variation of 5-HT2A receptor and response to clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Genetic variation of the 5-HT2A receptor and response to clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Schizophrenia and the serotonin-2A receptor promoter polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Research Diagnoses for Tardive Dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Serotonin-2A receptor gene is not associated with symptomatology of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Negative association between T102C polymorphism of the 5-HT2a receptor gene and schizophrenia in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Association between allele 1 of T102C polymorphism, 5-hydroxytryptamine 2a receptor gene and schizophrenia in Chinese males in Singapore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

The expression of schizophrenia, affective disorder and vulnerability to tardive dyskinesia in an extensive pedigree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2801%2901076-9

10.1016/S0006-3223(01)01076-9

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference